Synthetic approaches to 1,2,4-triazolo[5,1-c][1,2,4]triazin-7-ones as basic heterocyclic structures of the antiviral drug Riamilovir ("Triazavirin®") active against SARS-CoV-2 (COVID-19)

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	1828-1837
Number of pages	10
Journal	Organic & biomolecular chemistry
Volume	20
Issue number	9
DOIs	https://doi.org/10.1039/d1ob02125g
Publication status	Published - 2 Mar 2022

IMINOPHOSPHORANE-MEDIATED SYNTHESIS, ETIOTROPIC THERAPY, STICKSTOFFHALTIGER HETEROCYCLEN, UBER 1.2.4-TRIAZINE, CYCLIZATION, DERIVATIVES, CHEMISTRY, INFLUENZA, ARVI

ID: 29718993